Valuation: Pfizer Inc

Market Cap 160B 137B 128B 117B 220B 15,308B 223B 1,515B 591B 7,690B 601B 588B 25,435B P/E 2026 *
17.6x
P/E 2027 * 13.8x
Enterprise Value 207B 178B 166B 152B 286B 19,851B 289B 1,965B 766B 9,972B 779B 762B 32,983B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.39x
Free-Float
59.05%
Yield 2026 *
6.13%
Yield 2027 * 6.18%
Manager TitleAgeSince
Chief Executive Officer 64 31/12/2018
Director of Finance/CFO 55 15/08/2026
Compliance Officer 65 30/11/2013
Director TitleAgeSince
Director/Board Member 68 31/08/2007
Director/Board Member 62 26/09/2013
Chairman 64 31/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+6.38%+76.86%+128.23% 1,119B
+1.07%+3.80%+51.03%+61.48% 651B
+1.20%+6.21%+26.47%+76.45% 468B
+1.02%+5.77%+43.09%+47.70% 374B
+0.85%+4.07%+23.88%+41.58% 302B
+1.26%+6.81%+1.59%+14.67% 259B
+1.88%+5.81%+48.54%+68.52% 238B
+1.59%+2.09%-15.52%-52.29% 208B
+1.87%+5.61%+25.81%+92.42% 181B
Average +1.29%+4.97%+31.31%+53.20% 422.21B
Weighted average by Cap. +1.14%+5.09%+44.31%+72.55%

Financials

2026 *2027 *
Net sales 62.24B 53.31B 49.88B 45.66B 85.7B 5,955B 86.83B 589B 230B 2,991B 234B 229B 9,894B 59.84B 51.26B 47.96B 43.9B 82.39B 5,725B 83.48B 567B 221B 2,876B 225B 220B 9,513B
Net income 8.9B 7.62B 7.13B 6.53B 12.26B 852B 12.42B 84.28B 32.87B 428B 33.42B 32.69B 1,415B 11.08B 9.49B 8.88B 8.13B 15.26B 1,060B 15.46B 105B 40.92B 533B 41.61B 40.7B 1,761B
Net Debt 47.48B 40.67B 38.06B 34.84B 65.38B 4,543B 66.24B 450B 175B 2,282B 178B 174B 7,549B 42.88B 36.73B 34.37B 31.46B 59.05B 4,103B 59.83B 406B 158B 2,061B 161B 158B 6,817B
Logo Pfizer Inc
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-